Colique néphrétique

Are Nonsteroidal Anti-inflammatory Drugs Safe and Effective for Treatment of Acute Renal Colic?

Katie Pettit, MD (EBEM Commentator), Julie L. Welch, MD (EBEM Commentator)

Department of Emergency Medicine, Indiana University School of Medicine, Indianapolis, IN


Take-Home Message

For patients presenting with acute renal colic, treatment with nonsteroidal anti-inflammatory drugs offers effective pain relief with fewer adverse effects than opioids or paracetamol.



Data Sources

The authors searched MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials, and Google Scholar through December 2016, World Health Organization International Clinical Trials Registry Platform through February 2017, and citations of retrieved articles, with no language restrictions.


Study Selection

Randomized controlled trials of acute renal colic comparing nonsteroidal anti-inflammatory drugs with opioids or nonsteroidal anti-inflammatory drugs with paracetamol, in any dose or route, were included. Primary outcomes included patient-reported reduction in pain at 30 minutes (pain variance based on the visual analog scale or numeric rating scale converted to a 0- to 100-point pain measure), complete or greater than or equal to 50% reduction in pain at 30 minutes (reported as failure of pain relief), adverse events, and need for rescue analgesia.


Data Extraction and Synthesis

Two authors independently screened studies for inclusion, extracted data, and assessed risk of bias. Discrepancies were resolved by consensus. Risk ratios and mean differences were used to measure treatment effects and adverse events. Study bias was assessed with the Cochrane Collaboration tool. Heterogeneity was reported with the I2 statistic, and subgroup analysis was performed to identify possible sources of heterogeneity. For pooled results with significant heterogeneity, a 95% prediction interval was calculated to clarify the observed and true effects.





Selected outcomes for nonsteroidal anti-inflammatory drugs compared with opioids in acute renal colic.

Outcome or Subgroup Analysis No. of Studies RR (95% CI) I2
Failure of complete relief at 30 min 13 0.96 (0.82–1.11) 49
Failure of ≥50% reduction in pain at 30 min 4 0.76 (0.47–1.22) 82
Need for rescue analgesia 17 0.73 (0.57–0.94) 52
Need for rescue analgesia by IV route 7 0.75 (0.60–0.93) 0
Adverse events 23 0.53 (0.40–0.69) 59
Vomiting as adverse event 14 0.41 (0.24–0.70) 54


RR, Risk ratio (<1 favors nonsteroidal anti-inflammatory drugs); IV, intravenous.

A total of 36 randomized controlled trials (including 4,887 patients) from 16 countries were included in this systematic review and meta-analysis. Outcomes for reduction in pain at 30 minutes found that nonsteroidal anti-inflammatory drugs had benefit over opioids (mean difference –5.58 on a 100-point scale; 95% confidence interval [CI] –10.22 to –0.95); however, there was substantial heterogeneity across studies (I2=81%), and subgroup analysis could not identify the source of the variability. The quality of evidence varied across outcomes and was deemed low quality for pain variance, complete or greater than or equal to 50% reduction in pain at 30 minutes, and need for rescue analgesia with nonsteroidal anti-inflammatory drugs. Detection and reporting bias was identified in 23 of the 36 studies.



It is estimated that 1.3 million people present to emergency departments (EDs) each year for visits relating to kidney stone disease.1Approximately 90% of stones less than 5 mm will pass spontaneously, making medical management an important treatment for this disease process.2Patients with acute renal colic present to the ED with the main expectation of pain relief. Patient length of stay depends on the time necessary to obtain symptom control because the majority of these patients (80%) will ultimately be discharged from the ED.1The main factors when an analgesia treatment is chosen are safety and efficacy.

This systematic review and meta-analysis addresses the optimal analgesic treatment for acute renal colic. The meta-analysis demonstrated no difference in initial pain control between nonsteroidal anti-inflammatory drugs and opioids (risk ratio 0.96; 95% CI 0.82 to 1.11). However, the data showed consistent treatment benefit for nonsteroidal anti-inflammatory drugs (requiring fewer rescue analgesic treatments), especially when given intravenously. The systematic review also reported that patients treated with nonsteroidal anti-inflammatory drugs were less likely to have an adverse event—specifically, fewer episodes of vomiting—compared with those treated with opioids. Because nausea and vomiting are part of the classic presentation of acute renal colic, the decreased rate of vomiting with nonsteroidal anti-inflammatory drugs is an important consideration. Outcomes examining the safety and efficacy between nonsteroidal anti-inflammatory drugs and paracetamol in renal colic found no difference between pain relief at 30 minutes or adverse events. However, nonsteroidal anti-inflammatory drugs had fewer requirements for rescue analgesia compared with paracetamol (risk ratio 0.56; 95% CI 0.42 to 0.74).

Although not addressed in the systematic review, emergency medicine clinicians need to consider the potential for adverse events when using nonsteroidal anti-inflammatory drugs for acute renal colic in certain patient populations; nonsteroidal anti-inflammatory drugs should be avoided in patients with poor renal function or in those having risk factors for decreased renal function.

In summary, for emergency physicians treating acute renal colic, nonsteroidal anti-inflammatory drugs should be considered first-line treatment because they offer effective pain relief with fewer adverse effects and less need for rescue analgesia compared with opioids or paracetamol. These findings are important in the context of the national opioid epidemic, declared a public health emergency in 2017, in which physicians are charged to advance better practices in pain management.3



  • Foster, G., Stocks, C., and Borofsky, M.S. Emergency Department Visits and Hospital Admissions for Kidney Stone Disease, 2009: Statistical Brief #139. (Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Available at:) (Accessed February 13, 2018)Agency for Healthcare Research & Quality, Rockville, MD; 2006
  • Barnela, S.R., Soni, S.S., Saboo, S.S. et al. Medical management of renal stone. Indian J Endocrinol Metab. 2012; 16: 236–239
  • US Department of Health and Human Services. About the US opioid epidemic. Available at: Updated February 12, 2018. Accessed February 13, 2018.


Votre commentaire

Entrez vos coordonnées ci-dessous ou cliquez sur une icône pour vous connecter:


Vous commentez à l’aide de votre compte Déconnexion /  Changer )

Photo Google

Vous commentez à l’aide de votre compte Google. Déconnexion /  Changer )

Image Twitter

Vous commentez à l’aide de votre compte Twitter. Déconnexion /  Changer )

Photo Facebook

Vous commentez à l’aide de votre compte Facebook. Déconnexion /  Changer )

Connexion à %s